Oaktree Acquisition Corp. III Life Sciences completes $175M IPO, funds placed in trust for acquisition

Oaktree Acquisition Corp. III Life Sciences

Completed IPO of 17,500,000 units at $10.00 per unit, generating gross proceeds of $175,000,000.
Private placement of 550,000 units to sponsor at $10.00 per unit, gross proceeds $5,500,000.
Net proceeds $175,000,000 placed in trust account for benefit of public shareholders.
On Oct 30, partial over-allotment exercise: 1,699,029 units ($16,990,290); sponsor bought 33,981 private placement units ($339,810).
Audited balance sheet as of Oct 25, 2024 shows $177.1M total assets, $175M in trust, shareholders' deficit of $(5.5M).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.